$GNPX
Genprex Inc

2019 Q1 Form 10-Q Financial Statement

#000156459019019363 Filed on May 15, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 Q1
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.660M $630.0K
YoY Change 163.49% -7.35%
% of Gross Profit
Research & Development $508.0K $51.62K
YoY Change 884.18% -24.49%
% of Gross Profit
Depreciation & Amortization $2.931K $947.00
YoY Change 209.5% 58.63%
% of Gross Profit
Operating Expenses $508.0K $51.62K
YoY Change 884.18% -24.49%
Operating Profit -$2.171M -$686.6K
YoY Change 216.15% -8.61%
Interest Expense $0.00 $7.398K
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$2.160M -$690.0K
YoY Change 213.04% -8.0%
Income Tax
% Of Pretax Income
Net Earnings -$2.159M -$694.0K
YoY Change 211.07% -7.63%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$140.8K -$58.77K
COMMON SHARES
Basic Shares Outstanding 15.54M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q1 2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.950M $20.00K
YoY Change 34650.0% -97.85%
Cash & Equivalents $6.946M $24.49K
Short-Term Investments
Other Short-Term Assets $100.0K $30.00K
YoY Change 233.33% 50.0%
Inventory
Prepaid Expenses
Receivables $0.00 $0.00
Other Receivables $0.00 $0.00
Total Short-Term Assets $7.050M $58.40K
YoY Change 11972.54% -93.85%
LONG-TERM ASSETS
Property, Plant & Equipment $30.00K $8.326K
YoY Change 260.32% -16.74%
Goodwill
YoY Change
Intangibles $388.7K $307.6K
YoY Change 26.38%
Long-Term Investments
YoY Change
Other Assets $404.8K $1.320M
YoY Change -69.32% 2539.32%
Total Long-Term Assets $426.4K $1.328M
YoY Change -67.89% 302.42%
TOTAL ASSETS
Total Short-Term Assets $7.050M $58.40K
Total Long-Term Assets $426.4K $1.328M
Total Assets $7.476M $1.386M
YoY Change 439.27% 8.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $210.0K $1.150M
YoY Change -81.74% 721.43%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $20.00K $280.0K
YoY Change -92.86% 833.33%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $231.1K $1.428M
YoY Change -83.82% 740.17%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $231.1K $1.428M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $230.0K $1.430M
YoY Change -83.92% 741.18%
SHAREHOLDERS EQUITY
Retained Earnings -$31.98M -$18.15M
YoY Change 76.25%
Common Stock $15.56K $11.76K
YoY Change 32.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.245M -$41.92K
YoY Change
Total Liabilities & Shareholders Equity $7.476M $1.386M
YoY Change 439.27% 8.31%

Cashflow Statement

Concept 2019 Q1 2018 Q1
OPERATING ACTIVITIES
Net Income -$2.159M -$694.0K
YoY Change 211.07% -7.63%
Depreciation, Depletion And Amortization $2.931K $947.00
YoY Change 209.5% 58.63%
Cash From Operating Activities -$1.642M -$203.7K
YoY Change 705.94% -68.63%
INVESTING ACTIVITIES
Capital Expenditures $4.111K $1.469K
YoY Change 179.85% -46.6%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$13.33K -$10.45K
YoY Change 27.54% -54.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 77.40K
YoY Change
NET CHANGE
Cash From Operating Activities -1.642M -203.7K
Cash From Investing Activities -13.33K -10.45K
Cash From Financing Activities 77.40K
Net Change In Cash -1.655M -136.8K
YoY Change 1110.19% -79.66%
FREE CASH FLOW
Cash From Operating Activities -$1.642M -$203.7K
Capital Expenditures $4.111K $1.469K
Free Cash Flow -$1.646M -$205.2K
YoY Change 702.17% -68.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
16135
CY2018Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
18085
CY2019Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
388671
CY2019Q1 us-gaap Assets
Assets
7476392
CY2019Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
24830
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2019Q1 us-gaap Depreciation
Depreciation
2931
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
508042
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1659796
CY2019Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
404806
CY2019Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
206251
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
231081
CY2019Q1 gnpx Investment Unit
InvestmentUnit
0
CY2019Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
15562
CY2019Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
39213286
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-31983537
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
7245311
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7476392
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15560765
CY2019Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15560765
CY2019Q1 us-gaap Revenues
Revenues
0
CY2019Q1 us-gaap Costs And Expenses
CostsAndExpenses
2170769
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2170769
CY2019Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
11923
CY2019Q1 us-gaap Interest Expense
InterestExpense
0
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-694001
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
15335772
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11738294
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-2158846
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-2158846
CY2018Q1 us-gaap Profit Loss
ProfitLoss
-694001
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
523022
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
223512
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-9297
CY2018Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8006
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-136593
CY2018Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
9595
CY2019Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
1950
CY2018Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
0
CY2019Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
0
CY2018Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
252515
CY2019Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-88818
CY2018Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
519934
CY2019Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-67922
CY2018Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
0
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1641793
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-203712
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4111
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1469
CY2019Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
9220
CY2018Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
8983
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13331
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10452
CY2019Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0
CY2018Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
77398
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
77398
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1655124
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-136766
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8600918
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
161251
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6945794
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
24485
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
0
CY2018Q1 us-gaap Interest Paid Net
InterestPaidNet
0
CY2019Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2018Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2019Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.60
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.94
CY2018Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2019Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
6695367
CY2018Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
8465768
CY2019Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Use of Estimates</font></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of our condensed financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. </p>
CY2019Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2019Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
6.6841954
CY2019Q1 gnpx Capital Stock Shares Authorized
CapitalStockSharesAuthorized
210000000
CY2019Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2019Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2018Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2019Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2018 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2019Q1 gnpx Number Of Patents
NumberOfPatents
32
CY2019Q1 gnpx Number Of Allowed Patents
NumberOfAllowedPatents
1
CY2019Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
4500000
CY2019Q1 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.08
CY2019Q1 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2020-08-13
CY2019Q1 us-gaap Debt Instrument Description
DebtInstrumentDescription
If no event of default occurs prior to August 13, 2020, the Promissory Note and all related interest will be cancelled.
CY2019Q1 gnpx Warrant Right To Purchase Percentage
WarrantRightToPurchasePercentage
0.80
CY2019Q1 gnpx Warrant Discount Rate
WarrantDiscountRate
0.20
CY2019Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.001
CY2014Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.001
CY2014Q1 gnpx Conversion Of Stock Shares Issued And Forward Stock Split
ConversionOfStockSharesIssuedAndForwardStockSplit
1235219
CY2013Q4 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2500000
CY2018Q2 gnpx Warrant To Purchase Shares Of Common Stock
WarrantToPurchaseSharesOfCommonStock
38400
CY2019Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
121617
CY2019Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
192274
CY2018 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
200009
CY2018 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
553303
CY2018Q2 gnpx Non Voting Common Stock Conversion Ratio
NonVotingCommonStockConversionRatio
1
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5905583
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
91813
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y1M28D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y9M29D
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2628749
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2034525
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
127593
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1461715
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.31
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.21
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.31
CY2017Q4 gnpx Percentage Applied On Outstanding Shares For Warrant To Purchase Shares Of Common Stock
PercentageAppliedOnOutstandingSharesForWarrantToPurchaseSharesOfCommonStock
0.03
CY2019Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019Q1 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.21
CY2019Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.00
CY2018Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
9600000

Files In Submission

Name View Source Status
0001564590-19-019363-index-headers.html Edgar Link pending
0001564590-19-019363-index.html Edgar Link pending
0001564590-19-019363.txt Edgar Link pending
0001564590-19-019363-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gnpx-10q_20190331.htm Edgar Link pending
gnpx-20190331.xml Edgar Link completed
gnpx-20190331.xsd Edgar Link pending
gnpx-20190331_cal.xml Edgar Link unprocessable
gnpx-20190331_def.xml Edgar Link unprocessable
gnpx-20190331_lab.xml Edgar Link unprocessable
gnpx-20190331_pre.xml Edgar Link unprocessable
gnpx-ex311_6.htm Edgar Link pending
gnpx-ex312_8.htm Edgar Link pending
gnpx-ex321_7.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending